Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy

Retina

Volumn 20, Issue 2, 2000, Pages 151-155

  Song, Mi Kyoung ^a   Karavellas, Marietta P ^a   MacDonald, J Christopher ^a   Plummer, Daniel J ^a   Freeman, William R ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Cytomegalovirus retinitis; Highly active antiretroviral therapy failure

Indexed keywords

ANTIRETROVIRUS AGENT; CIDOFOVIR; DIDANOSINE; GANCICLOVIR; INDINAVIR; LAMIVUDINE; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ARTICLE; CYTOMEGALOVIRUS; FEMALE; HIGH RISK PATIENT; HUMAN; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RETINITIS; VIRUS LOAD; VIRUS REACTIVATION;

EID: 0034049891     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200002000-00007     Document Type: Article

References (24)

1. Centers for Disease Control and Prevention. Update: trends in AIDS incidence. MMWR Morb Mortal WkIy Rep 1997;46: 165-173.
2. Horowitz HW, Telzak EE, Sepkowitz KA, Wormser GP. Human immunodeficiency virus infection, part II. Dis Mon 1998; 44:677-716.
3. Jabs DA, Bartlett JG. AIDS and ophthalmology: a period of transition. Am J Ophthalmol 1997;124:227-233.
4. Mitchell SM, Membrey WL, Youle MS, et al. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2-year prospective study. Br J Ophthalmol 1999;83: 652-655.
5. Doan S, Cochereau I, Guvenisik N, et al. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol 1999;128:250-251.
6. Kaplan NM, Palmer BF, Skiest DJ. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy (HAART). Am J Med Sci 1999;317:318-335.
7. Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 1997;277:1519-1520.
8. Macdonald JC, Torriani FJ, Morse LS, et al. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis 1998;177:1182-1187.
9. + counts. Ophthalmology 1998; 105:1259-1264.
10. Tural C, Romeu J, Sirera G, et al. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis 1998;177:1080-1083.
11. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol 1997;124: 199-205.
12. Whitcup SM, Cunningham ET Jr, Polis MA, Fortin E. Spontaneous and sustained resolution of CMV retinitis in patients receiving highly active antiretroviral therapy. Br J Ophthalmol 1998;82:845-846.
13. Karavellas MP, Lowder CY, Macdonald JC, et al. Immune recovery vitritis associated with inactive cytomegalovirus retinitis. Arch Ophthalmol 1998;116:169-175.
14. Zegans ME, Walton RC, Holland GN, et al. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol 1998;125:292-300.
15. Sanislo SR, Lowder CY, Kaiser PK. Optic nerve head neovascularization in a patient with inactive cytomegalovirus retinitis and immune recovery. Am J Ophthalmol 1998;126:318-320.
16. Canzano JC, Reed JB, Morse LS. Vitreomacular traction syndrome following highly active antiretroviral therapy in AIDS patients with cytomegalovirus retinitis. Retina 1998;18:443-447.
17. Newsome R, Casswell T, O'Moore E, Fisher M. Cystoid macular oedema in patients with AIDS and cytomegalovirus retinitis on highly active antiretroviral therapy. Br J Ophthalmol 1998;82:456-457.
18. + lymphocyte responses in HIV+ patients. Br J Ophthalmol 1998;82:988-990.
19. Holland GN, Buhles WC Jr, Mastre B, Kaplan HJ. A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. Arch Ophthalmol 1989;107: 1759-1766.
20. Gross JG, Bozzette SA, Mathews WC, et al. Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology 1990;97:681-686.
21. Flores-Aguilar M, Munguia D, Besen G, et al. Clinical versus fundus photographic evaluation of the status of cytomegalovirus retinitis in AIDS patients. Retina 1996;16:363-372.
22. + T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat Med 1998;4:953-956.
23. Perrin L, Telenti A. HIV treatment failure: testing for HIV resistance in clinical practice. Science 1998;280:1871-1873.
24. Schrier RD, Freeman WR, Wiley CA, McCutchan JA. Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J Clin Invest 1995;95:1741-1746.